Position in LLY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,068,507,846
+$127,594,253 QoQ
Shares Held
1,161,712
+32.7% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
2.96%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026APG Asset Management N.V. holds $2,004,717,268 across 8 Drug Manufacturers - General names. LLY ranks #1 (53.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,161,712 | $1,068,507,846 | |
| 2 | ABBV |
AbbVie Inc.
|
1,248,938 | $271,631,525 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,708,121 | $205,469,875 | |
| 4 | AMGN |
Amgen Inc
|
395,935 | $139,309,729 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
994,609 | $138,618,656 | |
| 6 | PFE |
Pfizer Inc
|
3,044,539 | $85,490,655 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,323,671 | $80,280,646 | |
| 8 | BIIB |
Biogen Inc.
|
84,047 | $15,408,336 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,068,507,846 | 1,161,712 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $940,913,593 | 875,529 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $667,289,280 | 874,560 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $679,556,836 | 871,752 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $689,420,113 | 834,740 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $632,386,116 | 819,153 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $120,895,372 | 136,460 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $636,681,323 | 703,220 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $512,743,322 | 659,087 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $408,936,450 | 701,531 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $472,562,676 | 879,792 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $452,916,497 | 965,748 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $343,021,976 | 998,841 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $404,299,661 | 1,105,127 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $139,482,196 | 431,366 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $174,868,587 | 539,335 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $174,706,318 | 610,072 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $179,397,155 | 649,472 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $273,418,100 | 1,183,372 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $285,745,973 | 1,244,972 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $241,133,431 | 1,290,726 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $272,093,426 | 1,611,546 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $205,705,910 | 1,389,717 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $220,559,247 | 1,343,399 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $145,158,688 | 1,046,415 | Shares | Defined | 2020-05-19 | |
| No filing history on record for this holder in this stock. | ||||||